A detailed history of Cwm, LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Cwm, LLC holds 1,800 shares of DVAX stock, worth $23,112. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,800
Previous 1,288 39.75%
Holding current value
$23,112
Previous $14,000 42.86%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$10.05 - $11.61 $5,145 - $5,944
512 Added 39.75%
1,800 $20,000
Q2 2024

Jul 09, 2024

BUY
$10.73 - $12.58 $6,888 - $8,076
642 Added 99.38%
1,288 $14,000
Q1 2024

Apr 05, 2024

BUY
$11.7 - $14.98 $2,152 - $2,756
184 Added 39.83%
646 $8,000
Q4 2023

Feb 01, 2024

SELL
$13.09 - $14.98 $1,793 - $2,052
-137 Reduced 22.87%
462 $6,000
Q3 2023

Oct 11, 2023

BUY
$12.64 - $14.99 $1,074 - $1,274
85 Added 16.54%
599 $9,000
Q2 2023

Aug 03, 2023

BUY
$9.85 - $13.17 $5,033 - $6,729
511 Added 17033.33%
514 $7,000
Q1 2023

Apr 28, 2023

SELL
$9.44 - $11.88 $3,521 - $4,431
-373 Reduced 99.2%
3 $0
Q4 2022

Feb 01, 2023

BUY
$10.27 - $13.29 $328 - $425
32 Added 9.3%
376 $4,000
Q3 2022

Oct 27, 2022

BUY
$9.93 - $17.44 $3,415 - $5,999
344 New
344 $4,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.62B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.